Evidence map›Paper›PMID 12163970›Full record

ArticleSurgical endoscopy2002

Local recurrence and survival after laparoscopic mesorectal resection forrectal adenocarcinoma.

E C Poulin, C M Schlachta, R Grégoire, P Seshadri, M O Cadeddu, J Mamazza

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Article
  3. Current Status of Minimally Invasive Surgery for Rectal Cancer.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2016
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Laparoscopy for rectal cancer: the need for randomized trials.Clinics in colon and rectal surgery · 2006
    Article
  12. Article
  13. Review
  14. [Present treatment strategies for rectal carcinoma].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2005
    Article
  15. Article
  16. Article
  17. [Surgical therapy of rectal carcinoma].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2003
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

E C PoulinCentre for Minimally Invasive Surgery, St. Michael's Hospital, University of Toronto, 30 Bond Street, Ontario, Canada M5B1W8. eric.poulin@utoronto.ca
C M Schlachta
R Grégoire
P Seshadri
M O Cadeddu
J Mamazza

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLaparoscopic resection for rectal cancer is controversial. Actuarial survival and local recurrence rates have not been determined.

methodsA prospective database containing 80 consecutive unselected laparoscopic resections of rectal cancers performed between November 1991 and 1999 was reviewed. Local recurrence was defined as any detectable local disease at follow-up assessment occurring either alone or in conjunction with generalized recurrence. The tumor node metastases (TNM) classification for colorectal cancers and the Kaplan-Meier method were used to determine staging and survival curves. The mesorectal excision technique was used during surgery.

resultsThe median follow-up period was 31 months for patients with stages I, II, and III cancer, and 15.5 months for patients with stage IV cancer. The overall 5-year survival rate was 65.1% for all cancer stages and 72.1% for stages I, II, and III cancer. No trocar-site recurrence was observed. The overall local recurrence rate was 3.75% (3/80) for all cancer stages, and 4.3% (3/70) for stages I, II, and III cancer.

conclusionsThe survival and local recurrence rates for patients with rectal cancer treated by laparoscopic mesorectal excision do not differ negatively from those in the literature for open mesorectal excision. Further validation is needed.

Indexed as

Neoplasm Recurrence, LocalAdenocarcinomaAgedAged, 80 and overFemaleFollow-Up StudiesHumansLaparoscopyMaleMiddle AgedNeoplasm StagingProspective StudiesRectal NeoplasmsSurvival RateTreatment Outcome

Identifiers

PMID12163970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.